» Articles » PMID: 33605032

Signaling at the Endosome: Cryo-EM Structure of a GPCR-G Protein-beta-arrestin Megacomplex

Overview
Journal FEBS J
Specialty Biochemistry
Date 2021 Feb 19
PMID 33605032
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

G protein-coupled receptors (GPCRs) are a large class of cell-surface receptor involved in cellular signaling that are currently the target of over one third of all clinically approved therapeutics. Classically, an agonist-bound, active GPCR couples to and activates G proteins through the receptor intracellular core. To attenuate G protein signaling, the GPCR is phosphorylated at its C-terminal tail and/or relevant intracellular loops, allowing for the recruitment of β-arrestins (βarrs). βarrs then couple to the receptor intracellular core in order to mediate receptor desensitization and internalization. However, our laboratory and others have observed that some GPCRs are capable of continuously signaling through G protein even after internalization. This mode of sustained signaling stands in contrast with our previous understanding of GPCR signaling, and its molecular mechanism is still not well understood. Recently, we have solved the structure of a GPCR-G protein-βarr megacomplex by cryo-electron microscopy. This 'megaplex' structure illustrates the independent and simultaneous coupling of a G protein to the receptor intracellular core, and binding of a βarr to a phosphorylated receptor C-terminal tail, with all three components maintaining their respective canonically active conformations. The structure provides evidence for the ability of a GPCR to activate G protein even while being bound to and internalized by βarr. It also reveals that the binding of G protein and βarr to the same GPCR is not mutually exclusive, and raises a number of future questions to be answered regarding the mechanism of sustained signaling.

Citing Articles

Tail engagement of arrestin at the glucagon receptor.

Chen K, Zhang C, Lin S, Yan X, Cai H, Yi C Nature. 2023; 620(7975):904-910.

PMID: 37558880 PMC: 10447241. DOI: 10.1038/s41586-023-06420-x.


Altered Signaling and Desensitization Responses in PTH1R Mutants Associated with Eiken Syndrome.

Portales-Castillo I, Dean T, Cheloha R, Creemer B, Vilardaga J, Savransky S Commun Biol. 2023; 6(1):599.

PMID: 37268817 PMC: 10238420. DOI: 10.1038/s42003-023-04966-0.


Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief.

Hegron A, Peach C, Tonello R, Seemann P, Teng S, Latorre R Proc Natl Acad Sci U S A. 2023; 120(22):e2220979120.

PMID: 37216510 PMC: 10235985. DOI: 10.1073/pnas.2220979120.


Fusion of the β-adrenergic receptor with either Gαs or βarrestin-2 produces constitutive signaling by each pathway and induces gain-of-function in BEAS-2B cells.

Lucero-Garcia Rojas E, Reyes-Alcaraz A, Ruan K, McConnell B, Bond R FASEB Bioadv. 2022; 4(12):758-774.

PMID: 36479208 PMC: 9721090. DOI: 10.1096/fba.2022-00038.


β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the same GPCR in living cells.

Haider R, Matthees E, Drube J, Reichel M, Zabel U, Inoue A Nat Commun. 2022; 13(1):5638.

PMID: 36163356 PMC: 9512828. DOI: 10.1038/s41467-022-33307-8.


References
1.
Vilardaga J, Jean-Alphonse F, Gardella T . Endosomal generation of cAMP in GPCR signaling. Nat Chem Biol. 2014; 10(9):700-6. PMC: 4417940. DOI: 10.1038/nchembio.1611. View

2.
Oakley R, Laporte S, Holt J, Barak L, Caron M . Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem. 1999; 274(45):32248-57. DOI: 10.1074/jbc.274.45.32248. View

3.
Feinstein T, Yui N, Webber M, Wehbi V, Stevenson H, King Jr J . Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. J Biol Chem. 2013; 288(39):27849-60. PMC: 3784700. DOI: 10.1074/jbc.M112.445098. View

4.
Reiter E, Ahn S, Shukla A, Lefkowitz R . Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol. 2011; 52:179-97. PMC: 3628752. DOI: 10.1146/annurev.pharmtox.010909.105800. View

5.
Lohse M, Benovic J, CODINA J, Caron M, Lefkowitz R . beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science. 1990; 248(4962):1547-50. DOI: 10.1126/science.2163110. View